Promotion of Medical Innovation from Academia Worldwide by Construction and Utilization of Worldwide Research Mapping System by the University of Tokyo

  • SDG3 Ensure healthy lives and promote well-being for all at all ages
  • SDG17 Strengthen the means of implementation and revitalize the global partnership for sustainable development
Nobuhito Saito
Translational Research Initiative
Director / the University of Tokyo Hospital Professor
The TRI (Translational Research Initiative) has developed a web-based system (Research Mapping System: RMS) that dramatically increases the efficiency of listing, grasping and utilization of research programs at the University of Tokyo. RMS is a program that allows you to easily select researchers and research results of interest to corporations in order to promote academia-industry collaboration in the medical field, and more than 215 researchers from across 12 related departments are registered. A total of 40 companies has already subscribed to and used this system. These companies are selecting research topics and researchers of interest from the RMS, while confirming the details of each research and promoting relationships with researchers through the TRI.

This system has been revised and now it has been made accessible to both domestic and overseas academia. This change allows for information sharing among researchers and their research programs beyond the boundaries of universities and research institutions. Furthermore, granting access rights to various medical-related enterprises makes it easier to match innovation seeds (or research seeds) owned by academia around the world and corporate needs. This will in turn likely encourage innovation through industry-academia collaboration greatly. This powerful IT support tool helps the University of Tokyo fulfill its responsibilities as one of Japan’s core universities.

This system serves as a tool to connect many universities in Japan and abroad, it is thus deemed desirable to transfer the management and operation functions to a company independent from the university. Even so, the RMS program is created by the university’s investment and thus an asset of the university, just as is often the case with companies, the University of Tokyo is the largest single shareholder and retain its central position.

The RMS is a powerful tool for promoting innovation from academia
The Translational Research Initiative
Sharing the RMS with universities worldwide helps complete a virtually integrated data source for academia research assets
The Translational Research Initiative

Related links

Research collaborators

- We aim to establish a company through the in-kind investment of RMS from the University of Tokyo. Establish a stable management foundation by collecting access rights (usage fee) to RMS from companies and academia
Access Map
Close
Kashiwa Campus
Close
Hongo Campus
Close
Komaba Campus
Close